Role of basal inflammatory status as a predictor of survival in bevacizumab-treated advanced non-small cell lung cancer (NSCLC) patients.

被引：0
|
作者：
Botta, C.
Guglielmo, A.
Bestoso, E.
Apollinari, S.
Licchetta, A.
Blardi, P.
Tassone, P.
Chiriaco, G.
Barbieri, V.
Mantovani, G.
Tagliaferri, P.
Correale, P.
机构：
[1] Siena Univ Hosp, Ist Toscano Tumori, Med Oncol Unit, Dept Oncol, Siena, Italy
[2] Sect Med Oncol, Siena, Italy
[3] Siena Univ Hosp, Dept Clin Pharmacol, Siena, Italy
[4] Univ Catanzaro, Sch Med, Sect Med Oncol, Catanzaro, Italy
[5] Magna Graecia Univ Catanzaro, Med Oncol Unit, Catanzaro, Italy
[6] Tommaso Campanella Canc Ctr, Catanzaro, Italy
[7] Univ Cagliari, Dept Med Oncol, Cagliari, Italy
[8] Siena Univ Hosp, Dept Oncol, Med Oncol Unit, Siena, Italy
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2011年 / 29卷 / 15期
关键词：
D O I：
10.1200/jco.2011.29.15_suppl.7582
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
7582
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Differences in circulating angiogenic biomarkers as prognosticator for outcome in bevacizumab-treated nonsquamous non-small cell lung cancer (NSCLC) patients.
    Batus, Marta
    Pithadia, Ravi
    Kubasiak, John
    Fhied, Cristina
    Ibrahem, Zahraa
    Melinamani, Shruthi
    Fughhi, Ibdihaj
    Lie, Wen-Rong
    Basu, Sanjib
    Fidler, Mary J.
    Bonomi, Philip D.
    Borgia, Jeffrey Allen
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [2] Prognostic values of inflammatory indexes in bevacizumab-treated patients with advanced non-small-cell lung cancer
    Yang, Jingru
    Deng, Mingliang
    Bi, Minghong
    Wang, Yaping
    Qiao, Xuxu
    Zhang, Shanshan
    FUTURE SCIENCE OA, 2022, 8 (05):
  • [3] VeriStrat predicts survival in patients with non-small cell lung cancer (NSCLC) treated with erlotinib and bevacizumab
    Salmon, J. S.
    Dang, T. P.
    Billheimer, D.
    Roder, H.
    Grigorieva, J.
    Tsypin, M.
    Herbst, R. S.
    Tsao, A. S.
    Tran, H.
    Carbone, D. P.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [4] Differences in Circulating Angiogenic Biomarkers as Prognosticator for Outcome in Bevacizumab-Treated Nonsquamous Non-Small Cell Lung Cancer (NSCLC) Patients
    Batus, M.
    Pithadia, R.
    Kubasiak, J.
    Fhied, C.
    Ibrahem, Z.
    Melinamani, S.
    Fughhi, I.
    Lie, W.
    Basu, S.
    Fidler, M.
    Bonomi, P. D.
    Borgia, J. A.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2014, 90 : S75 - S75
  • [5] Response to chemotherapy as a predictor of survival in advanced non-small cell lung cancer (NSCLC)
    Soussi, Ghassen
    Racil, Hajer
    Bacha, Saoussen
    Rouhou, Sana Cheikh
    Zidi, Asma
    Ayadi, Aida
    Chaouch, Nawel
    Chabbou, Abdellatif
    EUROPEAN RESPIRATORY JOURNAL, 2015, 46
  • [6] SYSTEMIC INFLAMMATORY STATUS AT BASELINE AFFECTS SURVIVAL AND BEVACIZUMAB ACTIVITY IN NON SMALL CELL LUNG CANCER (NSCLC) PATIENTS
    Botta, Cirino
    Guglielmo, Annamaria
    Barbieri, Vito
    Rocco, Danilo
    Rossi, Marcello
    Bestoso, Elena
    Apollinari, Serena
    Licchetta, Antonella
    Blardi, Patrizia
    Tassone, Pierfrancesco
    Chiriaco, Giorgio
    Tagliaferri, Pierosandro
    Correale, Pierpaolo
    JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : S1016 - S1017
  • [7] QUANTITATIVE MODELING AND SURVIVAL ANALYSIS IN NON-SMALL CELL LUNG CANCER (NSCLC) PATIENTS.
    Lee, T.
    Cao, Y.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2022, 111 : S29 - S29
  • [8] VeriStrat® classifier for survival and time to progression in non-small cell lung cancer (NSCLC) patients treated with erlotinib and bevacizumab
    Carbone, David P.
    Salmon, J. Stuart
    Billheimer, Dean
    Chen, Heidi
    Sandler, Alan
    Roder, Heinrich
    Roder, Joanna
    Tsypin, Maxim
    Herbst, Roy S.
    Tsao, Anne S.
    Tran, Hai T.
    Dang, Thao P.
    LUNG CANCER, 2010, 69 (03) : 337 - 340
  • [9] Systemic inflammatory status at baseline predicts bevacizumab benefit in advanced non-small cell lung cancer patients
    Botta, Cirino
    Barbieri, Vito
    Ciliberto, Domenico
    Rossi, Antonio
    Rocco, Danilo
    Addeo, Raffaele
    Staropoli, Nicoletta
    Pastina, Pierpaolo
    Marvaso, Giulia
    Martellucci, Ignazio
    Guglielmo, Annamaria
    Pirtoli, Luigi
    Sperlongano, Pasquale
    Gridelli, Cesare
    Caraglia, Michele
    Tassone, Pierfrancesco
    Tagliaferri, Pierosandro
    Correale, Pierpaolo
    CANCER BIOLOGY & THERAPY, 2013, 14 (06) : 469 - 475
  • [10] Comorbidity and survival in advanced non-small cell lung cancer (NSCLC) veteran patients
    Chang, V. T.
    Hoover, D. R.
    Cogswell, J.
    Cholankeril, M.
    Badin, S.
    Yang, W.
    Yan, H.
    Gonzalez, M. L.
    Einhorn, J.
    Kasimis, B. S.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
12345